One World Products (OWPC) Return on Capital Employed (2019 - 2025)
One World Products (OWPC) recorded quarterly Return on Capital Employed of 122.73% in Q3 2025, up 297.64% quarter-over-quarter from 30.87% in Q2 2025, and up 4314.0% on a YoY basis from 2.78% in Q3 2024.
One World Products (OWPC) Return on Capital Employed (2019 - 2025) Analysis & Trends
One World Products' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 122.73% for Q3 2025.
- In Q3 2025, Return on Capital Employed rose 4314.0% year-over-year to 122.73%; the TTM figure through Sep 2025 stood at 122.73% (up 4314.0% YoY), while the FY2024 annual figure was 60.68%, down 3226.0% from the prior year.
- Return on Capital Employed was 122.73% for Q3 2025 at One World Products, up from 30.87% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 707.62% in Q2 2023 to a low of 2284.26% in Q1 2021.
- Historically, Return on Capital Employed has averaged 167.3% across 5 years, with a median of 30.87% in 2025.
- The sharpest annual moves came in 2021 and 2022: Return on Capital Employed plunged 1039171 bps in 2021, then jumped 213830 bps in 2022.
- A 5-year view of Return on Capital Employed shows it stood at 176.39% in 2021, then tumbled by 38 bps to 243.03% in 2022, then surged by 137 bps to 90.12% in 2023, then sank by 31 bps to 62.47% in 2024, then surged by 96 bps to 122.73% in 2025.
- The last three Return on Capital Employed figures came in at 122.73% (Q3 2025), 30.87% (Q2 2025), and 36.66% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | One World Products | - | - | 48,591.00 | 122.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 122.73% |
| Jun 30, 2025 | 30.87% |
| Mar 31, 2025 | 36.66% |
| Dec 31, 2024 | 62.47% |
| Sep 30, 2024 | 79.59% |
| Jun 30, 2024 | 89.37% |
| Mar 31, 2024 | 131.21% |
| Dec 31, 2023 | 90.12% |
| Sep 30, 2023 | 147.82% |
| Jun 30, 2023 | 707.62% |
| Mar 31, 2023 | -1,047.16% |
| Dec 31, 2022 | -243.03% |
| Sep 30, 2022 | -229.04% |
| Jun 30, 2022 | -120.64% |
| Mar 31, 2022 | -145.97% |
| Dec 31, 2021 | -176.39% |
| Sep 30, 2021 | -147.06% |
| Jun 30, 2021 | -283.54% |
| Mar 31, 2021 | -2,284.26% |
| Dec 31, 2020 | 4,552.18% |